The ANTICOV clinical trial is looking for safe and affordable drugs to treat early COVID1-9 patients and prevent hospitalization. In Guinea, the study is carried out by Alliance for International Medical Action (ALIMA), Agence Nationale de Recherche sur le Sida et les Hépatites Virales (ANRS), and Université de Bordeaux - Institut National de la Santé et de la Recherche Médicale (INSERM). Visit the trial site & meet the clinical team.
